
Terressa M. Boykin
Examiner (ID: 5881, Phone: (571)272-1069 , Office: P/1765 )
| Most Active Art Unit | 1765 |
| Art Unit(s) | 1764, 1207, 1711, 1796, 1503, 1765 |
| Total Applications | 4786 |
| Issued Applications | 4211 |
| Pending Applications | 203 |
| Abandoned Applications | 406 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5337258
[patent_doc_number] => 20090053722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'SDAD ASSAY AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/193505
[patent_app_country] => US
[patent_app_date] => 2008-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18038
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053722.pdf
[firstpage_image] =>[orig_patent_app_number] => 12193505
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/193505 | SDAD ASSAY AND USES THEREOF | Aug 17, 2008 | Abandoned |
Array
(
[id] => 5342771
[patent_doc_number] => 20090181421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'DIAGNOSIS OF FETAL ABNORMALITIES USING NUCLEATED RED BLOOD CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/172158
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13363
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181421.pdf
[firstpage_image] =>[orig_patent_app_number] => 12172158
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/172158 | DIAGNOSIS OF FETAL ABNORMALITIES USING NUCLEATED RED BLOOD CELLS | Jul 10, 2008 | Abandoned |
Array
(
[id] => 303472
[patent_doc_number] => 07534608
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-19
[patent_title] => 'Methods of producing pancreatic hormones'
[patent_app_type] => utility
[patent_app_number] => 12/167227
[patent_app_country] => US
[patent_app_date] => 2008-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 114
[patent_no_of_words] => 80951
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534608.pdf
[firstpage_image] =>[orig_patent_app_number] => 12167227
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/167227 | Methods of producing pancreatic hormones | Jul 1, 2008 | Issued |
Array
(
[id] => 6178175
[patent_doc_number] => 20110178170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'GRISEOFULVIN ANALOGUES FOR THE TREATMENT OF CANCER BY INHIBITION OF CENTROSOMAL CLUSTERING'
[patent_app_type] => utility
[patent_app_number] => 12/666730
[patent_app_country] => US
[patent_app_date] => 2008-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16931
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20110178170.pdf
[firstpage_image] =>[orig_patent_app_number] => 12666730
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/666730 | GRISEOFULVIN ANALOGUES FOR THE TREATMENT OF CANCER BY INHIBITION OF CENTROSOMAL CLUSTERING | Jun 29, 2008 | Abandoned |
Array
(
[id] => 5349381
[patent_doc_number] => 20090004742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'SELECTION OF ANTIGEN-SPECIFIC T CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/144318
[patent_app_country] => US
[patent_app_date] => 2008-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2438
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20090004742.pdf
[firstpage_image] =>[orig_patent_app_number] => 12144318
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/144318 | SELECTION OF ANTIGEN-SPECIFIC T CELLS | Jun 22, 2008 | Abandoned |
Array
(
[id] => 5484910
[patent_doc_number] => 20090274675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'Migraine tonic'
[patent_app_type] => utility
[patent_app_number] => 12/214563
[patent_app_country] => US
[patent_app_date] => 2008-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4076
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20090274675.pdf
[firstpage_image] =>[orig_patent_app_number] => 12214563
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/214563 | Migraine tonic | Jun 20, 2008 | Abandoned |
Array
(
[id] => 5416379
[patent_doc_number] => 20090042266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THERERIN'
[patent_app_type] => utility
[patent_app_number] => 12/141976
[patent_app_country] => US
[patent_app_date] => 2008-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 31060
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20090042266.pdf
[firstpage_image] =>[orig_patent_app_number] => 12141976
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/141976 | TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THERERIN | Jun 18, 2008 | Abandoned |
Array
(
[id] => 5303526
[patent_doc_number] => 20090298178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'GROWTH FACTORS FOR PRODUCTION OF DEFINITIVE ENDODERM'
[patent_app_type] => utility
[patent_app_number] => 12/132437
[patent_app_country] => US
[patent_app_date] => 2008-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18174
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298178.pdf
[firstpage_image] =>[orig_patent_app_number] => 12132437
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/132437 | GROWTH FACTORS FOR PRODUCTION OF DEFINITIVE ENDODERM | Jun 2, 2008 | Abandoned |
Array
(
[id] => 4711868
[patent_doc_number] => 20080300394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'DEFECTIVE SINDBIS VIRAL VECTORS'
[patent_app_type] => utility
[patent_app_number] => 12/123790
[patent_app_country] => US
[patent_app_date] => 2008-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 19300
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20080300394.pdf
[firstpage_image] =>[orig_patent_app_number] => 12123790
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/123790 | DEFECTIVE SINDBIS VIRAL VECTORS | May 19, 2008 | Abandoned |
Array
(
[id] => 4781059
[patent_doc_number] => 20080289058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Targeted delivery of glycine receptors to excitable cells'
[patent_app_type] => utility
[patent_app_number] => 12/152310
[patent_app_country] => US
[patent_app_date] => 2008-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9777
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0289/20080289058.pdf
[firstpage_image] =>[orig_patent_app_number] => 12152310
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/152310 | Targeted delivery of glycine receptors to excitable cells | May 13, 2008 | Abandoned |
Array
(
[id] => 4778847
[patent_doc_number] => 20080286845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'FERMENTATION PROCESS'
[patent_app_type] => utility
[patent_app_number] => 12/115084
[patent_app_country] => US
[patent_app_date] => 2008-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7803
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286845.pdf
[firstpage_image] =>[orig_patent_app_number] => 12115084
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/115084 | FERMENTATION PROCESS | May 4, 2008 | Abandoned |
Array
(
[id] => 6631475
[patent_doc_number] => 20100100979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'BIOMARKER SPECIFIC FOR CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/531358
[patent_app_country] => US
[patent_app_date] => 2008-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55437
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20100100979.pdf
[firstpage_image] =>[orig_patent_app_number] => 12531358
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/531358 | Biomarker specific for cancer | Mar 12, 2008 | Issued |
Array
(
[id] => 4847971
[patent_doc_number] => 20080184379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Screening Method With The Use Of TBK1 Knockout Mouse'
[patent_app_type] => utility
[patent_app_number] => 12/037589
[patent_app_country] => US
[patent_app_date] => 2008-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7673
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20080184379.pdf
[firstpage_image] =>[orig_patent_app_number] => 12037589
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/037589 | Screening Method With The Use Of TBK1 Knockout Mouse | Feb 25, 2008 | Abandoned |
Array
(
[id] => 8103421
[patent_doc_number] => 08153358
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-10
[patent_title] => 'Selection and enrichment of proteins using in vitro compartmentalization'
[patent_app_type] => utility
[patent_app_number] => 12/035872
[patent_app_country] => US
[patent_app_date] => 2008-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 11113
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/153/08153358.pdf
[firstpage_image] =>[orig_patent_app_number] => 12035872
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/035872 | Selection and enrichment of proteins using in vitro compartmentalization | Feb 21, 2008 | Issued |
Array
(
[id] => 8421940
[patent_doc_number] => 08278428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-02
[patent_title] => 'Mitochondrial nucleic acid delivery systems'
[patent_app_type] => utility
[patent_app_number] => 12/526878
[patent_app_country] => US
[patent_app_date] => 2008-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 19990
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12526878
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/526878 | Mitochondrial nucleic acid delivery systems | Feb 17, 2008 | Issued |
Array
(
[id] => 4711096
[patent_doc_number] => 20080299622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Starch Hydrolysis Using Phytase with an Alpha Amylase'
[patent_app_type] => utility
[patent_app_number] => 12/027104
[patent_app_country] => US
[patent_app_date] => 2008-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21462
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299622.pdf
[firstpage_image] =>[orig_patent_app_number] => 12027104
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/027104 | Starch Hydrolysis Using Phytase with an Alpha Amylase | Feb 5, 2008 | Abandoned |
Array
(
[id] => 4845464
[patent_doc_number] => 20080181872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'AAV VECTORS ENCODING SUPEROXIDE DISMUTASE'
[patent_app_type] => utility
[patent_app_number] => 11/970138
[patent_app_country] => US
[patent_app_date] => 2008-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7897
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20080181872.pdf
[firstpage_image] =>[orig_patent_app_number] => 11970138
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/970138 | AAV VECTORS ENCODING SUPEROXIDE DISMUTASE | Jan 6, 2008 | Abandoned |
Array
(
[id] => 4764685
[patent_doc_number] => 20080175896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Tweak-pseudomonas exotoxin a fusion protein for cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 11/998518
[patent_app_country] => US
[patent_app_date] => 2007-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8435
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20080175896.pdf
[firstpage_image] =>[orig_patent_app_number] => 11998518
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/998518 | Tweak-pseudomonas exotoxin a fusion protein for cancer therapy | Nov 29, 2007 | Abandoned |
Array
(
[id] => 6032668
[patent_doc_number] => 20110055936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'TRANSGENIC MAMALS MODIFIELD IN BRI PROTEIN EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/312735
[patent_app_country] => US
[patent_app_date] => 2007-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12823
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20110055936.pdf
[firstpage_image] =>[orig_patent_app_number] => 12312735
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/312735 | TRANSGENIC MAMALS MODIFIELD IN BRI PROTEIN EXPRESSION | Nov 19, 2007 | Abandoned |
Array
(
[id] => 4820189
[patent_doc_number] => 20080226556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Removal promoters and inhibitor for apoptosis cells in vivo'
[patent_app_type] => utility
[patent_app_number] => 11/984033
[patent_app_country] => US
[patent_app_date] => 2007-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10139
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226556.pdf
[firstpage_image] =>[orig_patent_app_number] => 11984033
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/984033 | Removal promoters and inhibitor for apoptosis cells in vivo | Nov 12, 2007 | Abandoned |